CompanyDrug

Kelun-Biotech’s ADC for Cancer Gets NMPA Review, Expands MSD Collaboration

CompanyDeals

Eli Lilly Partners with Haya Therapeutics to Tap the Dark Genome for Obesity Treatments

CompanyDrug

Roche’s Columvi for Relapsed DLBCL Gets Review Nod from China’s CDE for New Indication

CompanyDrug

Jiangsu Hengrui’s Ivarmacitinib for Adult Alopecia Areata Accepted for Review by China’s CDE

Policy / RegulatoryR&D

US Allows Science and Technology Agreement with China to Expire, Pointing to Deepening R&D Competition

Company

Novartis Builds Two Radioligand Therapy Facilities in U.S. to Expand Cancer Treatment Capabilities

Deals

Jiangsu Suzhou Launches $843 Million Biomedicine Fund to Boost Pharma and Medical Device Innovation

CompanyDeals

Sage Group Expands into China’s Healthcare Market with Cenponts Healthcare Partnership

CompanyDrug

Hanx Biopharmaceuticals Receives NMPA Approval for HX009 Combination Therapy Phase II Trial

CompanyDeals

E-commerce and Physical Stores to Stock Hanmi’s OTC Drugs Following Shanghai Pharma Deal

Company

Aspen Pharmacare’s 2024 Fiscal Report Shows Mixed Results Amid China’s VBP Impact

CompanyDrug

European Commission Approves Merck’s Keytruda-Padcev Combo for First-Line Urothelial Carcinoma Treatment